Telephone-Based Cancer Education With or Without Telephone-Based Counseling in Young Participants

Sponsor
Georgetown University (Other)
Overall Status
Completed
CT.gov ID
NCT00459238
Collaborator
National Cancer Institute (NCI) (NIH)
104
1
50
2.1

Study Details

Study Description

Brief Summary

RATIONALE: Telephone-based cancer education and counseling may help participants learn about ways of preventing cancer and choose a lifestyle that will help them stay healthy as they grow older.

PURPOSE: This randomized clinical trial is studying telephone-based cancer education and telephone-based counseling to see how well they work compared with telephone-based cancer education alone in young participants.

Condition or Disease Intervention/Treatment Phase
  • Other: counseling intervention
  • Other: educational intervention
N/A

Detailed Description

OBJECTIVES:

Primary

  • Compare the efficacy of telephone-based cancer education with vs without counseling in younger participants.

Secondary

  • Determine the mechanisms by which education with counseling may impact cancer-relevant cognitive and behavioral outcomes.

  • Identify teens who may be most and least likely to benefit from education with counseling.

OUTLINE: This is a pilot, controlled, randomized study. Participants are stratified according to age (13-14 years vs 15 years vs 16 years vs 17 years vs 18-21 years), gender, race (white vs black vs other), and health status (chronic disease vs no chronic disease). Participants are randomized to 1 of 2 education arms.

  • Arm I: Participants undergo cancer education sessions via telephone over 45 minutes once a week for 8 weeks.

  • Arm II: Participants under cancer education sessions as in arm I and counseling techniques during the same telephone sessions.

In both arms, participants receive an intervention kit by mail before the first telephone call. The intervention kit includes age-appropriate self-help materials.

PROJECTED ACCRUAL: A total of 300 participants will be accrued for this study.

Study Design

Study Type:
Interventional
Actual Enrollment :
104 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
A Telephone-Based Education and Prevention Intervention for Teens and Young Adults
Actual Study Start Date :
Oct 1, 2006
Actual Primary Completion Date :
Dec 1, 2009
Actual Study Completion Date :
Dec 1, 2010

Outcome Measures

Primary Outcome Measures

  1. Multiple risk factor index [6 months]

  2. Knowledge [6 months]

  3. Health history taking [3 months]

  4. Nutrition [6 months]

  5. Physical activity [6 months]

  6. Tobacco use intentions and behavior [6 months]

  7. Alcohol use intentions and behavior [6 months]

  8. Screening intentions [6 months]

  9. Self-efficacy [6 months]

  10. Perceived benefits [6 months]

  11. Perceived barriers [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
13 Years to 21 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
DISEASE CHARACTERISTICS:
  • No life-threatening illness (e.g., cancer)

  • Chronic illnesses (e.g., asthma, diabetes) allowed with permission by physician

PATIENT CHARACTERISTICS:
  • No serious restrictions on physical activity, diet, or nutrition, including any of the following:

  • Untreated exercise-induced asthma

  • Orthopedic or neurological problems

  • Medical conditions affecting nutritional status, intestinal absorption, or response to nutritional intervention (e.g., inflammatory bowel disease)

  • No serious mental illness or developmental disability that would preclude study compliance, including eating disorders

  • Must adequately understand, speak, and read English

PRIOR CONCURRENT THERAPY:
  • Not specified

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, D.C. District of Columbia United States 20007

Sponsors and Collaborators

  • Georgetown University
  • National Cancer Institute (NCI)

Investigators

  • Study Chair: Kenneth Tercyak, PhD, Lombardi Comprehensive Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Georgetown University
ClinicalTrials.gov Identifier:
NCT00459238
Other Study ID Numbers:
  • CDR0000538178
  • R03CA119686
  • P30CA051008
  • GUMC-2006-243
First Posted:
Apr 11, 2007
Last Update Posted:
May 17, 2017
Last Verified:
Feb 1, 2017
Keywords provided by Georgetown University

Study Results

No Results Posted as of May 17, 2017